Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,978 public trials 744 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study

NCT01110200

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Florence, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
View all 103 locations
View Trial Details
Completed

Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma

NCT01181895

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Huntington Beach, California, United States
  • GSK Investigational Site Orlando, Florida, United States
  • GSK Investigational Site Tallahassee, Florida, United States
  • GSK Investigational Site Lawrenceville, Georgia, United States
View all 34 locations
View Trial Details
Completed

GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease

NCT00950807

Conditions
Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +11 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site Upland, California, United States
  • GSK Investigational Site Cincinnati, Ohio, United States
View all 19 locations
View Trial Details
Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Combination of GSK573719 and GW642444 in Subjects With COPD

NCT01039675

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Chester, South Carolina, United States
  • GSK Investigational Site Gaffney, South Carolina, United States
  • GSK Investigational Site Greenville, South Carolina, United States
  • GSK Investigational Site Greenwood, South Carolina, United States
View Trial Details
Completed

A Non-Interventional Safety Study of Balsamic Bactrim

NCT02902640

Conditions
Bronchial Diseases, Bronchitis, Infections, +4 more
Locations
  • Clínica Providencia; Centro de Investigación de Enfermedades Respiratorias Lima, Peru
  • Clinica de Especialidades Medicas Lima, Peru
  • Clinica San Borja; Instituto de Enfermedades Respiratorias EFEH Lima, Peru
  • Centro de Investigaciones Medicas/Hospital Maria Auxiliadora San Juán de Miraflores, Peru
View Trial Details
Completed

Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease

NCT02157935

Conditions
COPD Patients, Chronic Disease, Disease Attributes, +6 more
Locations
  • Research Site Andalusia, Alabama, United States
  • Research Site Andalusia, Alabama, United States
  • Research Site Birmingham, Alabama, United States
  • Research Site Birmingham, Alabama, United States
View all 371 locations
View Trial Details

Related conditions